Emerging interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors or degraders as therapeutic agents for autoimmune diseases and cancerYifan Feng, Tiantai Zhang, Hai‐Yu Hu et al.|Acta Pharmaceutica Sinica B|2024Cited by 29
Recent advances in interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors and PROTACsYifan Feng, Tiantai Zhang, Chengjuan Chen et al.|Chinese Chemical Letters|2025Cited by 2